Benzinga · Aug 10, 2026
UBS Maintains Buy on Shoulder Innovations, Raises Price Target to $28
UBS analyst Patrick Wood maintains Shoulder Innovations (NYSE:SI) with a Buy and raises the price target from $27 to $28.
SI
NYSE · SI
SHOULDER INNOVATIONS, INC.
Healthcare · Medical - Specialties
$22.06
Down-$0.04 (-0.18%)
Updated Aug 24, 2026, 12:12 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 306.35M
- P/E ratio
- -9.49
- Dividend yield
- 0.00%
- 52-week range
- $10.92 – $24.60
- Volume
- 106.2K
- Avg. volume
- 85.19K
Price performance
SI price history
1M range · 20 trading sessions · Daily adjusted prices
SI closed at $22.06 after 20 trading sessions, up 5.25% for the selected period.
- Last close
- $22.06
- Period change
- +5.25%
- Period low
- $19.23
- Period high
- $24.25
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $22.09 | $22.78 | $21.88 | $22.06 | 106.2K |
| Aug 20, 2026 | $22.88 | $22.88 | $21.60 | $22.10 | 96.48K |
| Aug 19, 2026 | $21.21 | $23.32 | $20.71 | $23.26 | 228.92K |
| Aug 18, 2026 | $19.97 | $21.62 | $19.97 | $21.13 | 127.65K |
| Aug 17, 2026 | $20.70 | $20.705 | $19.50 | $19.92 | 82.88K |
| Aug 14, 2026 | $19.19 | $21.02 | $18.88 | $20.73 | 249.77K |
| Aug 13, 2026 | $19.65 | $19.9758 | $19.16 | $19.23 | 86.87K |
| Aug 12, 2026 | $19.57 | $19.63 | $18.65 | $19.34 | 103.07K |
| Aug 11, 2026 | $20.85 | $21.32 | $19.48 | $19.63 | 154.66K |
| Aug 10, 2026 | $20.38 | $21.28 | $19.7601 | $20.75 | 149.04K |
| Aug 7, 2026 | $22.88 | $22.88 | $18.765 | $20.59 | 286.87K |
| Aug 6, 2026 | $22.25 | $23.1561 | $22.045 | $22.43 | 40.41K |
| Aug 5, 2026 | $23.00 | $23.00 | $22.27 | $22.60 | 54.86K |
| Aug 4, 2026 | $22.13 | $23.065 | $22.13 | $22.69 | 178.86K |
| Aug 3, 2026 | $22.81 | $23.30 | $22.35 | $22.38 | 65.64K |
| Jul 31, 2026 | $23.00 | $23.245 | $22.44 | $22.74 | 79.17K |
| Jul 30, 2026 | $23.35 | $23.93 | $22.73 | $23.19 | 112.31K |
| Jul 29, 2026 | $23.90 | $24.595 | $23.07 | $23.72 | 167.37K |
| Jul 28, 2026 | $21.64 | $24.54 | $21.091 | $24.25 | 144.3K |
| Jul 27, 2026 | $20.47 | $21.184 | $20.24 | $20.96 | 51.57K |
Latest SI news
The latest Smart Investors Daily articles mentioning SI.
Stock researchCompany · Overview
SI research
Overview
Company profile and research snapshot.
Company profile
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $20.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | UBS | Buy | — |
| Aug 7, 2026 | Piper Sandler | Overweight | — |
| Aug 7, 2026 | BTIG | Buy | — |
| Jul 28, 2026 | UBS | Buy | — |
| May 8, 2026 | Piper Sandler | Overweight | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 7, 2026
Shoulder Innovations Files $300M Mixed Securities Shelf Prospectus And Registers Resale Of 8,103,026 Common Shares By Selling Stockholders
Common Stock, Preferred Stock,Debt Securities, Warrants, Subscription Rights and Units8,103,026 Shares of Common StockOffered by the Selling Stockholders From time to time, we may offer up to $300,000,000 aggregate
Benzinga · Aug 7, 2026
Piper Sandler Reiterates Overweight on Shoulder Innovations, Raises Price Target to $25
Piper Sandler analyst Matt O'Brien reiterates Shoulder Innovations (NYSE:SI) with a Overweight and raises the price target from $19 to $25.
Benzinga · Aug 7, 2026
BTIG Maintains Buy on Shoulder Innovations, Raises Price Target to $26
BTIG analyst Ryan Zimmerman maintains Shoulder Innovations (NYSE:SI) with a Buy and raises the price target from $24 to $26.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
